PPI‐amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta‐analysis-Reference-Cited by-同舟云学术

PPI‐amoxicillin dual therapy for Helicobacter pylori infection: An update based on a systematic review and meta‐analysis

Published:2020-04-20 Issue:4 Volume:25 Page:
ISSN:1083-4389
Container-title:Helicobacter
language:en
Short-container-title:Helicobacter

Author:

Gao Cai‐Ping¹,Zhang Di¹,Zhang Ting¹,Wang Jin‐Xia¹,Han Sheng‐Xi¹,Graham David Y.²^ORCID,Lu Hong³⁴^ORCID

Affiliation:

1. Department of Gastroenterology Sichuan Academy of Science & Sichuan Provincial People’s Hospital University of Electronic Science and Technology Chengdu China

2. Department of Medicine Michael E DeBakey Veterans Affairs Medical Center and Baylor College of Medicine Houston Texas

3. Division of Gastroenterology and Hepatology Key Laboratory of Gastroenterology & Hepatology Ministry of Health Shanghai Institute of Digestive Disease Renji Hospital School of Medicine Shanghai Jiao Tong University Shanghai China

4. Clinical Research Center Shanghai Jiao Tong University School of Medicine Shanghai China

Funder

Sichuan Academy of Science & Sichuan Provincial People's Hospital, University of Electronic Science and Technology

University of Electronic Science and Technology of China

Publisher

Wiley

Subject

Infectious Diseases,Gastroenterology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/hel.12692

Reference41 articles.

1. Systematic review with meta-analysis: the worldwide prevalence of Helicobacter pylori infection